Dimerix Limited

ASX (AUD): Dimerix Limited (DXB)

Last Price

0.495

Today's Change

+0.015 (3.12%)

Day's Change

0.465 - 0.515

Trading Volume

5,917,710

Overview

Market Cap

276 Million

Shares Outstanding

557 Million

Avg Volume

2,001,386

Avg Price (50 Days)

0.36

Avg Price (200 Days)

0.41

PE Ratio

-12.37

EPS

-0.04

Earnings Announcement

24-Feb-2025

Previous Close

0.48

Open

0.47

Day's Range

0.465 - 0.515

Year Range

0.16 - 0.665

Trading Volume

5,917,851

Price Change Highlight

1 Day Change

3.12%

5 Day Change

43.48%

1 Month Change

39.44%

3 Month Change

30.26%

6 Month Change

8.79%

Ytd Change

32.89%

1 Year Change

62.30%

3 Year Change

62.30%

5 Year Change

62.30%

10 Year Change

62.30%

Max Change

62.30%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs. It develops DMX-200 that is in two Phase 3 clinical trials for COVID respiratory complications; DMX-200, a Phase 3 clinical trial for focal segmental glomerulosclerosis disease; DMX-200 for diabetic kidney disease; and DMX-700 for chronic obstructive pulmonary disease. The company is headquartered in Fitzroy, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment